CRON Reports $45.2M Q1 Revenue, +40% YoY, $15.7M Net Income, $5.1M Adjusted EBITDA, $822M Cash
Cronos Group Inc. Common Share · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · Now $2.82
-2.9% in 7d after detection
Post-detection moves
1h
—
1d
+0.7%
3d
-0.4%
7d
-2.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS